FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/03/041425 [Registered on: 28/03/2022] Trial Registered Prospectively
Last Modified On: 23/03/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Role of Trikantakadi Guggulu And Ervarubijadi Kwath In The management of Chronic Kidney Disease 
Scientific Title of Study   A CLINICAL STUDY OF TRIKANTAKADI GUGGULU AND ERVARUBIJADI KWATH ANUPAN IN THE MANAGEMENT OF MUTRAGHAT W.S.R. CHRONIC KIDNEY DISEASE 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Awadhesh Sahu 
Designation  Pg Scholar Kayachikitsa Department  
Affiliation  Shri narayan prasad awasthi, Govt Ayurveda College Raipur C.G. 
Address  OPD no 2, Department of Kayachikitsa, Shri Narayan Prasad Awasthi Government Ayurveda College Raipur Chhattisgarh 492010

Raipur
CHHATTISGARH
492010
India 
Phone  7804989037  
Fax    
Email  drawadheshkumarsahu@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr S D Khichariya 
Designation  Lecturer Kayachikitsa  
Affiliation  Shri narayan prasad awasthi, Govt Ayurveda College Raipur C.G. 
Address  Department of Kayachikitsa, Shri Narayan Prasad Awasthi Government Ayurveda College Raipur Chhattisgarh 492010

Raipur
CHHATTISGARH
492010
India 
Phone  9826196400  
Fax    
Email  drkhichariya@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr S D Khichariya 
Designation  Lecturer Kayachikitsa  
Affiliation  Shri narayan prasad awasthi, Govt Ayurveda College Raipur C.G. 
Address  Department of Kayachikitsa, Shri Narayan Prasad Awasthi Government Ayurveda College Raipur Chhattisgarh 492010

Raipur
CHHATTISGARH
492010
India 
Phone  9826196400  
Fax    
Email  drkhichariya@gmail.com  
 
Source of Monetary or Material Support  
DEPARTMENT OF KAYACHIKITSA SHRI NARAYAN PRASAD AWASTHI GOVT. AYURVEDA COLLEGE RAIPUR C.G. 
 
Primary Sponsor  
Name  Department of Kayachikitsa Shri Narayan Prasad Awasthi Ayurveda College Raipur Chhattisgarh  
Address  Shri Narayan Prasad Awasthi Government Ayurveda College Raipur Chhattisgarh 492010 
Type of Sponsor  Other [Government Ayurveda College Raipur ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Awadhesh Sahu  Shri Khudadad Doongaji Govt. Ayurveda Hospital Raipur C.G.  Department of Kayachikitsa, OPD no.2 and IPD, Govt. Ayurveda hospital Raipur C.G.
Raipur
CHHATTISGARH 
7804989037

drawadheshkumarsahu@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Government Ayurveda College Raipur C.G.  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N189||Chronic kidney disease, unspecified. Ayurveda Condition: MUTRAGHATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Trikantakadi Guggulu, Reference: Yogratnakar Mutrakrichha Chikitsa 4 Page no. 58, Route: Oral, Dosage Form: Guggulu , Dose: 1(g), Frequency: qid, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: Ervarubijadi Kwath with added Punarnava and Corn Silk Extract), Additional Information: Ervarubijadi Kwath, Reference: -Ashtang Hridayam Chikitsa Sthan 11/8 Page no. 708
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Known CKD patients with Blood serum creatinine level less than 5 mg/dl, Blood urea level less than 100 mg/dl, Stable patients of DM type 2 or Hypertension 
 
ExclusionCriteria 
Details  Terminal stage of CKD patients, Ruled out renal stone patients, Patients need for hemodialysis, Blood serum creatinine level more than or equal to 5 mg/dl, Blood urea level more than or equal to 100 mg/dl, GFR less than 30ml/min, Unstable patient of DM type 2 or Hypertension, Cancer, AIDS, Corona  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduce the symptom of CKD  60 days 
 
Secondary Outcome  
Outcome  TimePoints 
improve the Quality of Life  60 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/04/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nill 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Mutraghat (chronic kidney disease) is a progressive form of Renal disorder and may appear at the stage of irreversible damage. CKD is identified by Blood test for Creatinine , which is a breakdown product of muscle metabolism. Higher level of Creatinine indicates a lower GFR and as a result decreased capability of the Kidneys to excrete products. The modern method of treatment is not satisfactory for CKD patients and causes many adverse reactions. A total number of 30 patients will be selected for this study and will be advised Trikantakadi gugglu with anupana of Eravarubijadi kwath added with punarnava and cornsilk extract for 60 days. During treatment follow up will be done weekly, and post treatment follow up will be done every 15 days. Assessment will be done on the basis of subjective and objective criteria adopted for this study.  
Close